NHPAP — Stock Film
STOCK FILMSCENE 1/10NHPAP · $23.05
Stock Expert AI presents
NHPAP
National Healthcare Properties, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
National Healthcare Properties, Inc. A quick introduction.

On the stock market since 2019, it operates in the world of real estate. It has 26 employees. Now — the numbers.

on the stock market since 2019
26 employees
$652.6M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $1.2.

The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
Sales are moving sideways.

No real growth (1% a year). Red columns mark years that ended in a loss.

$329.4M
2021
$335.8M
2022
$345.9M
2023
$353.8M
2024
$342.3M
2025
In the vault right now:
$0
DEBT: $1.1B
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
20
very weak

Clearly below the class average.

FINANCIAL STRENGTH
27
very weak

Clearly below the class average.

VALUATION
39
weak

Clearly below the class average.

GROWTH
75
strong

This grade is a blend: the profit side is strong, the sales tempo slow.

PRICE MOMENTUM
82
very strong

The stock has been running stronger than the market lately.

WORTH WATCHING

Business Quality: Profit power and business quality trail similar companies in the sector.

Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.

THE FIVE-YEAR JOURNEY
Trading below its recent peak.

The stock trades below its recent peak — about 13% off the top. A pullback, not a collapse.

1
THE BRIGHT SIDE · 1/2
The product is selling

Sales run at $342.3M a year. A small number, but proof the product has real buyers.

2
THE BRIGHT SIDE · 2/2
Pays a steady dividend

It pays out $1.84 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/2
Running at a loss

A loss of $57.6M against $342.3M in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/2
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
F
0 / 100 · MoonshotScore

On our five-subject report card, NHPAP sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: NHPAP is a high-risk stock — not yet profitable, and its future rides on its product catching on.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film